Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PatientPing helps accountable care organizations track patient care
September 4, 2016 -
Stride Health launches financial health app “Stride Drive” to protect 1099 income
August 31, 2016 -
Denali Therapeutics announces first clinical trial application, key collaborations and $130M Series B
August 25, 2016 -
Acacia Pharma announces positive results from a pivotal phase 3 trial of Baremsis™ for the treatment of post-operative nausea & vomiting
August 12, 2016 -
Inside Dr. Doug Melton and Semma Therapeutics’ effort to cure diabetes with stem cells
August 12, 2016 -
PatientPing partners with UMass Memorial for better interoperability
August 9, 2016 -
Editing out pesticides using CRISPR technology?
August 3, 2016 -
Harvard Business Review
Personalized recommendation engines like Iora Health are coming to health care
July 6, 2016 -
US HealthVest announces $50 Million in Series B round funding to expand behavioral and mental health coverage
June 30, 2016 -
F-Prime Capital ranked #2 in top 100 biotech VCs
June 27, 2016 -
Stem cell factory opens door for trials of personalized diabetes treatment
June 16, 2016 -
Iora Health named an innovator in primary care
May 16, 2016 -
Vermont to employ PatientPing to coordinate care
April 12, 2016 -
Acacia Pharma initiates second phase e treatment trial with BAREMSIS™, expects NDA filing in 2016
March 21, 2016 -
VitalWare Completes Financing to Accelerate Growth of SaaS Solutions for Healthcare Providers
February 26, 2016 -
Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology
February 25, 2016 -
New York Startup, Quartet Health, Finds the Right Algorithm for Mental Health
February 1, 2016 -
Steward ACO Picks Quartet Health for Behavioral Health IT
January 29, 2016 -
Eris Launches Major Expansion of Standard Swap Futures
January 26, 2016 -
USHealthVest’s Chicago Behavioral Hospital launches center for veterans’ mental health
January 21, 2016 -
TraceLink Announces NEXUS ’16: Mastering Global Traceability with a Digital Supply Chain Network
January 20, 2016 -
Aclaris Therapeutics Initiates Phase 3 Clinical Trials Of A-101 For The Treatment Of Seborrheic Keratosis
January 19, 2016 -
TraceLink Boosts Leadership Position as Proven Track and Trace Network Exceeds 200,000
January 14, 2016 -
Trivitron patents NeoMass AAAC kit for newborn screening to detect 50 inborn disorders
January 12, 2016 -
Stride Health Partners With Beam Dental To Redesign Dental Care For Self-Employed Americans
January 12, 2016 -
Liazon Named Winner Of Fall 2015 Digital Health Awards
January 12, 2016 -
Surface Oncology Partners with Novartis in $170M Deal to Pursue Next-Gen Cancer Immunotherapies
January 11, 2016 -
World’s First MRIdian Center Celebrates Two Years of MRI-Guided Radiation Treatments
January 11, 2016 -
Ironwood Pharmaceuticals Details Strategy To Build Top-Performing Commercial Biotechnology Company
January 11, 2016 -
Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
January 7, 2016 -
Procured Health Reports Significant Growth in 2015
January 6, 2016 -
Blueprint Medicines Strengthens Executive Leadership Team
January 5, 2016 -
Acacia Pharma reports positive results from study of BAREMSIS™
January 5, 2016 -
Blueprint Medicines Added to NASDAQ Biotechnology Index
December 17, 2015 -
Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma
December 14, 2015 -
Ping Identity Accelerates Disruption of Legacy Web Access Management Solutions as More Enterprises Embrace Cloud and Mobility
December 8, 2015 -
Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2015 Financial Results
December 4, 2015 -
Acacia Pharma: Dr Patrick Vink to Succeed Ian Kent as Non-Executive Chairman
December 3, 2015 -
Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference
December 3, 2015 -
Blueprint Medicines and PatientCrossroads Launch Registry for Mastocytosis Patients to Increase Understanding of Disease and Speed Therapeutic Development
December 1, 2015 -
Mersana Therapeutics to Present Poster at the 2015 San Antonio Breast Cancer Symposium
November 30, 2015 -
TraceLink, Roche and SPI Win GS1 Brazil Automation Award for RDC 54 Compliance Pilot
November 24, 2015 -
ViewRay® to Present at the LD Micro “Main Event” Microcap Conference
November 24, 2015 -
Proteostasis Therapeutics, Inc. Demonstrates Therapeutic Potential of a Proprietary Triple Combination Therapy for the Treatment of Cystic Fibrosis that Restores Activity of Mutant F508del CFTR Protein to 80% of Normal
November 20, 2015 -
Aclaris Therapeutics Reports Third Quarter 2015 Financial Results
November 18, 2015 -
PatientPing Announces $9.6M in Funding from Google Ventures, F-Prime Capital, and First Round to Build the First National Care Coordination Network
November 16, 2015 -
Semma Therapeutics Acquires Providence Biotech Company, CytoSolv, Inc.
November 16, 2015 -
TraceLink Ranked Number 293 Fastest Growing Company in North America on Deloitte’s 2015 Technology Fast 500(TM)
November 13, 2015 -
Tetraphase Pharmaceuticals to Provide Corporate Update at Stifel 2015 Healthcare Conference
November 12, 2015 -
ViewRay to Present at the Stifel 2015 Healthcare Conference
November 12, 2015 -
Ultragenyx to Present at Upcoming Investor Conferences
November 11, 2015 -
FORUM Pharmaceuticals Inc. Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program for Cognitive Impairment in Schizophrenia
November 11, 2015 -
WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in China
November 10, 2015 -
Dimension Therapeutics Announces Expansion of Internal Research and Process Development Capabilities
November 3, 2015 -
WuXi PharmaTech Launches Medical Device Testing Services in China
October 23, 2015 -
Dimension Therapeutics Announces Pricing of Initial Public Offering
October 22, 2015 -
ViewRay’s MRI-Guided Radiation Therapy System Receives Korean Regulatory Marketing Approval
October 20, 2015 -
WuXi PharmaTech Receives 2015 Asian CRO Company of the Year Award from Frost & Sullivan
October 16, 2015 -
Procured Health Announces Johns Hopkins Health System As New Client
October 14, 2015 -
Aclaris Therapeutics International and Rigel Sign License Agreement for JAK Inhibitors to Treat Skin Disorders
October 9, 2015 -
Proteostasis Therapeutics Announces Presentation of Data For Its CFTR Amplifier for Cystic Fibrosis
October 9, 2015 -
Ultragenyx Announces Aceneuramic Acid Prolonged Release Marketing Authorization Application Filed and Accepted for Review by European Medicines Agency
October 2, 2015 -
Collaboration for Alzheimer’s Prevention: An Initiative to Advance Alzheimer’s Disease Research
October 1, 2015 -
Quartet Health founder and CEO Arun Gupta on tech driving collaboration in behavioral health
September 19, 2015 -
Kyruus Gets $25M More for “Moneyball” Approach to Doctors and Patients
September 18, 2015 -
Aclaris Therapeutics International and Rigel Pharmaceuticals Sign License Agreement for JAK Inhibitors to Treat Skin Disorders
September 9, 2015 -
Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis
September 9, 2015 -
Proteostasis Therapeutics, Inc. Raises $37 Million in Crossover Financing
September 8, 2015 -
Ultragenyx Presents Data on Patients With Cardiomyopathy Treated with UX007
September 1, 2015 -
Symbiomix Therapeutics Announces That The FDA Has Granted Fast Track Designation To Its Single-Dose Bacterial Vaginosis Therapy, SYM-1219
August 27, 2015 -
ViewRay Completes Private Placement, Raises Aggregate of $29.4Million
August 20, 2015 -
Ironwood Advances Drug With Potential in ‘Huge Range of Diseases’
July 23, 2015 -
Adaptimmune Announces Interim Results from Pilot Trial of its Engineered NY-ESO T Cells
October 17, 2014 -
Fidelity Biosciences Leads Investment Into Avidity Nanomedicines
October 7, 2014
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.